Abstract
Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder primarily characterized by multiple café-au-lait macules, peripheral neurofibromas, skinfold freckling, and Lisch nodules. The causative genetic factor is the neurofibromin 1 gene (NF1), which encodes a Ras GTPase-activating protein called neurofibromin. NF1 variants may lead to loss of neurofibromin function and activation of downstream cell growth. This study aims to discover the disease-causing variants responsible for NF1 in two Han Chinese families by using exome sequencing combined with Sanger sequencing. A recurrent missense variant c.269T>C (p.Leu90Pro) and a novel nonsense variant c.2993dupA (p.Tyr998*) in the NF1 gene were identified. These variants co-segregated with the disorder in the pedigrees and were absent in the normal controls. The results broaden the NF1 mutation spectrum responsible for NF1. This may be helpful in genetic counseling, clinical management, and gene-targeted therapies for NF1.
Keywords
Gene-targeted therapy
Genetic analysis
Genetic counseling
NF1 gene
Neurofibromatosis type 1
MeSH 主题词
Adult
Female
Humans
Male
Middle Aged
Mutation, Missense
Neurofibromatosis 1/genetics,pathology
Neurofibromin 1/genetics
Pedigree
Polymorphism, Single Nucleotide
作者与单位
共 9 位作者,点击展开单位 / ORCID
Xiao Heng
Center for Experimental Medicine, the Third Xiangya Hospital, Central South University, Changsha, People's Republic of China. | Department of Neurology, the Third Xiangya Hospital, Central South University, Changsha, People's Republic of China. | Department of Pathology, the Third Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Yuan Lamei
Center for Experimental Medicine, the Third Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Xu Hongbo
Center for Experimental Medicine, the Third Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Yang Zhijian
Center for Experimental Medicine, the Third Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Huang Feizhou
Department of Hepatobiliary and Pancreatic Surgery, the Third Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Song Zhi
Department of Neurology, the Third Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Yang Yan
Department of Neurology, the Third Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Zeng Cheng
Center for Experimental Medicine, the Third Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Deng Hao
ORCID
Center for Experimental Medicine, the Third Xiangya Hospital, Central South University, Changsha, People's Republic of China. hdeng008@yahoo.com. | Department of Neurology, the Third Xiangya Hospital, Central South University, Changsha, People's Republic of China. hdeng008@yahoo.com.